Phreesia, Inc. (NYSE:PHR) COO Sells $48,159.30 in Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 1,785 shares of the business’s stock in a transaction dated Wednesday, January 15th. The stock was sold at an average price of $26.98, for a total value of $48,159.30. Following the transaction, the chief operating officer now directly owns 768,208 shares of the company’s stock, valued at $20,726,251.84. The trade was a 0.23 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

Evan Roberts also recently made the following trade(s):

• On Wednesday, January 8th, Evan Roberts sold 2,681 shares of Phreesia stock. The shares were sold at an average price of $27.95, for a total value of $74,933.95.
• On Monday, January 6th, Evan Roberts sold 2,873 shares of Phreesia stock. The stock was sold at an average price of $26.61, for a total value of $76,450.53.

Phreesia Stock Performance

Shares of PHR traded up $0.44 during mid-day trading on Friday, hitting $27.24. 309,924 shares of the company traded hands, compared to its average volume of 382,284. The stock has a market cap of $1.58 billion, a price-to-earnings ratio of -18.53 and a beta of 0.94. The stock has a 50-day moving average price of $23.42 and a two-hundred day moving average price of $22.77. Phreesia, Inc. has a 1 year low of $17.07 and a 1 year high of $29.16. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The company had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. During the same quarter last year, the firm posted ($0.58) earnings per share. The firm’s revenue was up 16.6% compared to the same quarter last year. Equities analysts anticipate that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages have recently weighed in on PHR. Needham & Company LLC restated a “buy” rating and issued a $29.00 price objective on shares of Phreesia in a report on Friday, January 10th. JMP Securities reiterated a “market outperform” rating and issued a $30.00 price target on shares of Phreesia in a report on Tuesday, December 10th. Truist Financial lifted their price objective on Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th. Robert W. Baird lowered their target price on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research note on Wednesday, December 11th. Finally, Citigroup upped their target price on shares of Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a research report on Friday, January 10th. Twelve analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $31.00.

Institutional Investors Weigh In On Phreesia

A number of hedge funds have recently modified their holdings of PHR. International Assets Investment Management LLC raised its holdings in Phreesia by 2,179.7% in the 3rd quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock worth $33,000 after purchasing an additional 1,395 shares during the period. Lombard Odier Asset Management USA Corp purchased a new stake in Phreesia in the second quarter worth about $202,000. Point72 DIFC Ltd bought a new position in shares of Phreesia in the second quarter worth about $209,000. XTX Topco Ltd purchased a new position in shares of Phreesia during the 3rd quarter valued at about $247,000. Finally, Hsbc Holdings PLC bought a new position in shares of Phreesia during the 2nd quarter valued at approximately $301,000. Institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.